Yeh S (1963) Relative incidence of skin cancer in Chinese in Taiwan: with special reference to arsenical cancer. Monogr Natl Cancer Inst
Chen K-P, Wu H-Y, Yeh C-C, Cheng Y-J (1979) Color Atlas of Cancer Mortality by Administrative and Other Classified Districts in Taiwan Area: 1968–1976. Taipei, Taiwan: National Science Council, NSC Special Publication No. 2.
Tseng W-P, Chu H-M, How S-H, Fong J-M, Lin C-S, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Nat Cancer Inst
Environmental Protection Agency (1984) Health Assessment Document for Inorganic Arsenic: Final Report. Washington, DC: US Environmental Protection Agency, EPA Publication EPA-600/8-83-022F.
Risk Assessment Forum (1988) Special Report on Ingested Inorganic Arsenic: Skin Cancer; Nutritional Essentiality. Washington, DC: US Environmental Protenction Agency, US EPA 625/3-87/013.
Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y (1985) Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan: high-arsenic artisan well water and cancers. Cancer Res
Chen C-J, Kuo T-L, Wu M-M (1988) Arsenic and cancers. Lancet
Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol
Brown KG, Chen C-J (1995) Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Analysis
Chen C-J, Wang C-J (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res
Lo M-C, Hsen Y-C, Lin B-K (1977) Second Report on the Investigation of Arsenic Content in Underground Water in Taiwan. Taichung, Taiwan: Taiwan Provincial Institute of Environmental Sanitation.
Guo H-R, Chen C-J, Greene HL (1994) Arsenic in drinking water and Cancers: a descriptive review of Taiwan studies. In: Chappell WR, Abernathy CO, Cothern CR, eds. Arsenic: Exposure and Health. Special Issue of Environmental Geochemistry and Health, vol. 16. Northwood, UK: Science and Technology Letters, pp. 129-138.
Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR (1997) Arsenic in drinking water and incidence of urinary cancers. Epidemiology
American Public Health Association (1985) Standard Methods of the Evaluation of Water and Water Waste. Washington, DC: American Public Health Association.
Greschonig H, Irgolic KJ (1995) The mercuric bromide stain method for the determination of arsenic: implications for the epidemiological studies in Taiwan. In: SEGH Second International Conference on Arsenic Exposure and Health Effects, Book of Abstracts. San Diego, CA: Society for Environmental Geochemistry and Health.
Guo H-R, Lipsitz SR, Hu H, Monson RR (1994) The dose-response relationship between arsenic in drinking water and skin cancers. In: Workshop on Arsenic: Epidemiology and PBPK Modeling, Book of Abstracts. Annapolis, MD: Society for Environmental Geochemistry and Health.
World Health Organization (1976) International Classification of Diseases for Oncology, 1st edn. Geneva: World Health Organization.
Guo H-R, Lipsitz SR, Hu H, Monson RR (1998) Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer. Environ Res
Rosenbaum PR, Rubin DB (1984) Difficulties with regression analysis of age-adjusted rates. Biometrics
Wu S-Y (1986) Report on the Degree of Urbanization of Precincts and Townships in Taiwan. Taipei, Taiwan: Bureau of Statistics, Executive Yuan.
Hutchinson J (1887) Arsenic cancer. Br Med J
Hutchinson J (1888) On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Trans Pathol Soc Lond
Lagerholm B, Skog E (1968) Squamous cell carcinoma in psoriasis vulgaris. Three cases of squamous cell carcinoma developing in psoriatic lesions. Acta Dermato-Venereologica
Southwick GJ, Schwartz RA (1979) Arsenically associated cutaneous squamous cell carcinoma with hypercalcemia. J Surg Oncol
Ismail R, Cheng PS (1988) Multiple Bowen's disease associated with squamous cell carcinoma — a report of a case. J Dermatol
Andrews PE, Farrow GM, Oesterling JE (1991). Squamous cell carcinoma of the scrotum: long-term folowup of 14 patients. J Urol
Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR (1999) Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br J Cancer
Jackson R, Grainge JW (1975) Arsenic and cancer. Can Med Assoc J
Bruynzeel I, Bergman W, Hartevelt HM, et al. (1991) High singledose European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol
Huang YZ, Qian XC, Wang GQ, et al. (1992) Syndrome of endemic arsenism and fluorosis. A clinical study. Chinese Med J
Wagner SL, Maliner JS, Morton WE, Braman RS (1979) Skin cancer and arsenical intoxication from well water. Arch Dermatol
Roat JW, Wald A, Mendelow H, Pataki KI (1982) Hepatic angiosarcoma associated with short-term arsenic ingestion. Am J Med
Nakjang Y, Kullavanijaya P (1994) Basal cell carcinoma: seven years' experience at the Institute of Dermatology in Bangkok. J Dermatol
Mowad CM, Jaworsky C, Werth VP (1996) Numerous erythematous truncal plaques. Multiple basal cell carcinomas associated with arsenic ingestion. Arch Dermatol
132: 1105-1106, 1108–1109.
Wong SS, Tan KC, Goh CL (1998) Cutaneous manifestations of chronic arsenicism: review of seventeen cases. J Am Acad Dermatol
Kim HJ, Min HG, Lee ES (1999). Bowen's diseases and basal cell carcinomas in a patient. J Dermatol
Boonchai W, Walsh M, Cummings M, Chenevix-Trench G (2000) Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch Dermatol
Yeh S, How SW, Lin CS (1968) Arsenical cancer of skin. Histologic study with special reference to Bowen's disease. Cancer
Yeh S, Chen HC, How SW, Deng CS (1974) Fine structure of Bowen's disease in chronic arsenicalism. J Natl Cancer Inst
Upshaw CB Jr, Bryant MF, Claiborne TS Jr (1979) Noncirrhotic portal hypertension after arsenic ingestion. South Med J
Heddle R, Bryant GD (1983). Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion. Chest
Tan SH, Tham SN, Goh CL (1995) Skin cancers at Tertiary Referral Skin Hospital in Singapore. Int J Dermatol
Murata K, Iwazawa T, Takayama T, Yamashita K, Okagawa K (1994) Quadruple cancer including Bowen's disease after arsenic injections 40 years earlier: report of a case. Surg Today
Ohnishi Y, Murakami S, Ohtsuka H, Miyauchi S, Shinmori H, Hashimoto K (1997) Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure? J Dermatol
Tsuruta D, Hamada T, Mochida K, Nakagawa K, Kobayashi H, Ishii M (1998) Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning. Br J Dermatol
Lien HC, Tsai TF, Lee YY, Hsiao CH (1999) Merkel cell carcinoma and chronic arsenicism. J Am Acad Dermatol
Shneidman D, Belizaire R (1986) Arsenic exposure followed by the development of dermatofibrosarcoma protuberans. Cancer
Yu HS, Chiou KS, Chen GS, Yang RC, Chang SF (1993) Progressive alterations of cytokeratin expressions in the process of chronic arsenism. J Dermatol
Guo H-R, Valberg PA (1997) Evaluation of the validity of the US EPA's cancer risk assessment for arsenic for low-level exposures: A likelihood ratio approach. Environ Geochem Health
Environmental Protection Agency (2001) National primary drinking water regulations: Arsenic and clarifications to compliance and new source contaminants monitoring; Final rule. Fed Reg
Lu F-J, Guo H-R, Chiang H-S, Hong C-L (1986) Relationships between the fluorescent intensity of well water and the incidence rate of bladder cancer. J Chinese Oncol Soc
Marcus WL, Rispin AS (1988) Threshold carcinogenicity using arsenic as an example. In: Cothern CR, Mehlman MA, Marcus WL, eds. Advanced Modern Environmental Toxicology, vol. XV: Risk Assessment and Risk Management of Industrial and Environmental Chemicals. Princeton, NJ: Princeton Publishing Co.
Uthus EO (1992) Evidence for arsenic essentiality. Environ Geochem Health
Mayer DR, Kosmus W, Pogglitsch H, Mayer D, Beyer W (1993) Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biol Trace Elem Res
Störer G (1991) Arsenic: opportunity for risk assessment. Arch Toxicol
Marczynski B (1988) Careinogenesis as the result of the deficiency of some essential trace elements. Med Hypoth
Karagas MR, Stukel TA, Morris JS, et al. (2001) Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol
Guo H-R (1997) Arsenic in drinking water and skin cancer: comparison among studies based on cancer registry, death certificates, and physical examinations. In: Abernathy CO, Cothern CR, Chappell WR, eds. Arsenic: Exposure and Health Effects. London: Chapman & Hall, pp. 234-259.